| 13 Nov 2025 |
Financial Performance Quarter 3 (F45) (Reviewed) (Revised) |
| 12 Nov 2025 |
Management Discussion and Analysis Quarter 3 Ending 30 Sep 2025 |
| 12 Nov 2025 |
Financial Performance Quarter 3 (F45) (Reviewed) |
| 12 Nov 2025 |
Financial Statement Quarter 3/2025 (Reviewed) |
| 06 Oct 2025 |
Invitation for shareholders to propose agenda items for the 2026 Annual General Meeting of Shareholders and to nominate candidates for directorship in advance. |
| 13 Aug 2025 |
Notification of the Resolution of the Board of Directors' Meeting No. 4/2025 Regarding the Interim Dividend Payment |
| 13 Aug 2025 |
Management Discussion and Analysis Quarter 2 Ending 30 Jun 2025 |
| 13 Aug 2025 |
Financial Performance Quarter 2 (F45) (Reviewed) |
| 13 Aug 2025 |
Financial Statement Quarter 2/2025 (Reviewed) |
| 30 Jun 2025 |
Report of the utilization of capital increase |
| 09 Jun 2025 |
Report on the results of sale of common shares offered to employee stock option program (F53-5) |
| 06 Jun 2025 |
Changing of Chief Accountant |
| 19 May 2025 |
Notification of the registration of an increase in registered capital and the amendment of Article 4 of the company's Memorandum of Association to reflect the capital increase with the Department of Business Development |
| 14 May 2025 |
Management Discussion and Analysis Quarter 1 Ending 31 Mar 2025 |
| 14 May 2025 |
Financial Performance Quarter 1 (F45) (Reviewed) |
| 14 May 2025 |
Financial Statement Quarter 1/2025 (Reviewed) |
| 29 Apr 2025 |
Publication of the Minutes of the 2025 AGM on the Company's Website |
| 23 Apr 2025 |
Shareholders meeting's resolution |
| 21 Apr 2025 |
Notification of the 2025 Company Special Holiday |
| 13 Mar 2025 |
Resolutions of the Board of Directors Meeting No. 1/2025 Regarding Dividend Suspension, Progress on the Disposal of Investment in Common Shares, Capital Increase, ESOP Issuance, Resignation of Company Secretary, and Scheduling of AGM 2025. (Revised) |
| 10 Mar 2025 |
Resolutions of the Board of Directors Meeting No. 1/2025 Regarding Dividend Suspension, Progress on the Disposal of Investment in Common Shares, Capital Increase, ESOP Issuance, Resignation of Company Secretary, and Scheduling of AGM 2025. (Revised) |
| 26 Feb 2025 |
Resolutions of the Board of Directors Meeting No. 1/2025 Regarding Dividend Suspension, Progress on the Disposal of Investment in Common Shares, Capital Increase, ESOP Issuance, Resignation of Company Secretary, and Scheduling of AGM 2025. |
| 26 Feb 2025 |
Management Discussion and Analysis Yearly Ending 31 Dec 2024 |
| 26 Feb 2025 |
Financial Performance Yearly (F45) (Audited) |
| 26 Feb 2025 |
Financial Statement Yearly 2024 (Audited) |
| 30 Jan 2025 |
Report of the utilization of capital increase |
